Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
92 participants
INTERVENTIONAL
2018-06-06
2019-06-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Vitamin D Supplementation on Severity of Pediatric Atopic Dermatitis
NCT01996423
Medium-Dose UVA1 Versus Narrow-Band UVB in Atopic Dermatitis
NCT00419406
Vitamin D Treatment Effect for Atopic Dermatitis in Children
NCT05523986
Effect of Oral Vitamin D Supplement on Atopic Dermatitis; A Clinical Trial With Staphylococcus Aureus Colonization Determination
NCT02058186
Analysis of Response of Subjects With Atopic Dermatitis or Psoriasis to Oral Vitamin D3
NCT00789880
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
treatment group
vitamin D plus topical 1% hydrocortisone cream twice daily
Vitamin D
Vitamin D plus topical 1% hydrocortisone cream twice daily
placebo group
placebo plus plus topical 1% hydrocortisone cream twice daily
Placebo
placebo plus topical 1% hydrocortisone cream twice daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitamin D
Vitamin D plus topical 1% hydrocortisone cream twice daily
Placebo
placebo plus topical 1% hydrocortisone cream twice daily
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. taking systemic corticosteroids or anti-inflammatory medications, prior vitamin D supplementation
3. receiving oral or topical antibiotics or topical calcineurin inhibitors for at least one week prior to enrollment
4. known gut absorption problem, presence of active skin infection at baseline any known hepatic and/or renal disease.
5 Years
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Hepatology & Tropical Medicine Research Institute
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Noha Mansour
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NHTRMI
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12-2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.